Reelin expression in Creutzfeldt-Jakob disease and experimental models of transmissible spongiform encephalopathies

• Published in: Molecular neurobiology 2017-10
• Main Authors: Mata, Agata, Urrea Zazurca, Laura, Vilches Saez, Silvia, Llorens Torres, Franc, Thüne, Katrin, Espinosa, Juan Carlos, Andréoletti, Olivier, Sevillano, Alejandro M, Torres, Juan Maria, Rodríguez Requena, Jesús, Zerr, Inga, Ferrer, Isidro (Ferrer Abizanda), Gavín Marín, Rosalina, Río Fernández, José Antonio del
• Format: Article
• Language: English
• Subjects: Creutzfeldt-Jakob disease; Extracellular matrix; Malaltia de Creutzfeldt-Jakob; Malalties per prions; Matriu extracel·lular; Metabolism; Metabolisme; Nerve tissue; Prion diseases; Teixit nerviós
• ISSN: 0893-7648

Reelin is an extracellular glycoprotein involved in key cellular processes in developing and adult nervous system, including regulation of neuronal migration, synapse formation, and plasticity. Most of these roles are mediated by the intracellular phosphorylation of disabled-1 (Dab1), an intracellular adaptor molecule, in turn mediated by binding Reelin to its receptors. Altered expression and glycosylation patterns of Reelin in cerebrospinal and cortical extracts have been reported in Alzheimer's disease. However, putative changes in Reelin are not described in natural prionopathies or experimental models of prion infection or toxicity. With this is mind, in the present study, we determined that Reelin protein and mRNA levels increased in CJD human samples and in mouse models of human prion disease in contrast to murine models of prion infection. However, changes in Reelin expression appeared only at late terminal stages of the disease, which prevent their use as an efficient diagnostic biomarker. In addition, increased Reelin in CJD and in in vitro models does not correlate with Dab1 phosphorylation, indicating failure in its intracellular signaling. Overall, these findings widen our understanding of the putative changes of Reelin in neurodegeneration.